Max Foundation partners with Novartis to combat PNH in low-resource countries
USA— The Max Foundation, a global nonprofit focused on advancing health equity, has expanded...
Read More
Tag: Novartis
Giovanni Caforio proposed as the Novartis’s board chairman
USA—Novartis, a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, has...
Read More
Novartis to acquire MorphoSys for US$2.9B to bolster oncology portfolio
SWITZERLAND – Novatis a pharmaceutical corporation based in Switzerland has revealed that...
Read More
Novartis to start pharmaceutical production of Pluvicto in the US
SWITZERLAND – Novartis plans to start commercial production of Pluvicto at its large-scale,...
Read More
Novartis settles long-running patent dispute, resolving Daiichi Sankyo lawsuit for US$180 million
USA – Novartis has reached a settlement, paying US$180 million to Daiichi Sankyo’s Plexxikon...
Read More
FDA approves Novartis’ Fabhalta, a groundbreaking oral monotherapy for rare blood disease treatment
SWITZERLAND — The U.S. Food and Drug Administration (FDA) has approved Novartis’ oral drug...
Read More
Emirates Oncology Society, Novartis ink breast cancer care deal
UAE – Novartis and the Emirates Oncology Society (EOS) have joined forces to launch a new...
Read More
Novartis and Alfa Labs unite to increase access to cardiovascular care
EGYPT – Novartis Pharma S.A.E. (Novartis Egypt) and Alfa Labs have joined forces to enhance the...
Read More
Novartis shuffles leadership as international markets leader departs
SWITZERLAND — Novartis, in the midst of a major organizational overhaul, is facing a significant...
Read More
Novartis advances spin-off of Sandoz, eyes growth in generics and biosimilars
SWITZERLAND — In a significant strategic move, Novartis has reaffirmed its commitment to the...
Read More
LATEST DIGITAL MAGAZINE
